What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Theravance, Inc (THRX) - Quote Info
great hit     26-Oct-09 11:15 am    
Theravance, Inc. (NASDAQ:THRX) has announced that they have received a US$20 million milestone payment after their new drug telavancin was approved by the Food and Drug Administration panel. In September 2009, FDA approved the telavancin injection which can be given once daily to patients suffering from complicated skin and skin structure infections that is caused by susceptible Gram positive bacteria. Approval of telavancin was based on data from 2 double-blind randomized Phase 3 trial where telavancin marketed as Vibativ demonstrated its efficacy and safety in clinical trials on patients suffering from various skin structure infections and strains. Although, Vibativ clearly got a green signal from the FDA panel there were some adverse reactions which were registered like taste disturbance, vomiting, nausea and foamy urine.
http://www.favstocks.com/theravance-mile...
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

liont10


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
great hit
liont10 Not rated 26-Oct-09 11:15 am  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Theravance Inc. (THRX)

Chart for Theravance Inc. (THRX)
On Nov 25: 13.13 0.00 (0.00%)
Symbol Lookup